Eagan, MN – April 20, 2005 – Biothera, the immune health company, is scheduled to present its business and technology to investors at 11:30 am on May 9 at the Minnesota Venture Capital Conference at the Sheraton Bloomington Hotel.

The annual conference is designed to connect venture capitalists, angel investors and investment bankers with emerging companies in need of capital.

The conference is sponsored in part by Twin Cities Business Monthly and New England Financial.

About Biothera, the Immune Health Company
Biothera is a biotechnology company dedicated to improving immune health. The company's primary focus is developing pharmaceuticals whose unique mechanism of action engages immune cells not normally involved in the fight against cancer. In addition, Biothera’s healthcare group manufactures and markets food-grade immune-enhancing ingredients for the nutritional supplement, functional food, cosmetic and the animal feed and nutrition markets.

Contact:
David Walsh
VP, Communications
Biothera, the Immune Health Company
651-256-4606
dwalsh@biotherapharma.com